Great West Life Assurance Co. Can purchased a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Rating) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 54,799 shares of the company’s stock, valued at approximately $4,283,000. Great West Life Assurance Co. Can owned 0.06% of Acadia Healthcare at the end of the most recent reporting period.
A number of other large investors have also bought and sold shares of the stock. First Horizon Advisors Inc. grew its position in shares of Acadia Healthcare by 153.9% in the 2nd quarter. First Horizon Advisors Inc. now owns 452 shares of the company’s stock worth $31,000 after buying an additional 274 shares during the last quarter. Point72 Hong Kong Ltd bought a new stake in shares of Acadia Healthcare in the 1st quarter worth approximately $38,000. C M Bidwell & Associates Ltd. bought a new stake in shares of Acadia Healthcare in the 2nd quarter worth approximately $39,000. James Investment Research Inc. bought a new stake in shares of Acadia Healthcare in the 2nd quarter worth approximately $50,000. Finally, Wipfli Financial Advisors LLC bought a new stake in shares of Acadia Healthcare in the 3rd quarter worth approximately $72,000. 99.79% of the stock is owned by hedge funds and other institutional investors.
Acadia Healthcare Trading Up 1.4 %
Acadia Healthcare stock opened at $84.62 on Monday. The company has a current ratio of 1.30, a quick ratio of 1.30 and a debt-to-equity ratio of 0.50. The business’s fifty day simple moving average is $83.82 and its two-hundred day simple moving average is $81.64. Acadia Healthcare Company, Inc. has a 12 month low of $50.07 and a 12 month high of $89.85. The company has a market capitalization of $7.70 billion, a price-to-earnings ratio of 27.30, a price-to-earnings-growth ratio of 1.97 and a beta of 1.26.
Wall Street Analyst Weigh In
A number of brokerages have recently weighed in on ACHC. Loop Capital upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $90.00 to $95.00 in a research report on Monday, December 12th. Stephens lifted their price objective on Acadia Healthcare from $86.00 to $88.00 and gave the stock an “equal weight” rating in a research report on Thursday, December 8th. Mizuho lifted their price target on Acadia Healthcare from $80.00 to $87.00 and gave the company a “neutral” rating in a research report on Thursday, December 8th. Royal Bank of Canada dropped their price target on Acadia Healthcare from $94.00 to $93.00 and set an “outperform” rating on the stock in a research report on Monday, December 12th. Finally, UBS Group dropped their price target on Acadia Healthcare to $96.00 in a research report on Friday, November 4th. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Acadia Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $89.90.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics.
- Get a free copy of the StockNews.com research report on Acadia Healthcare (ACHC)
- CVS Health is Growing into an Integrated Healthcare Organization
- NVIDIA Outlook Improving: Watchlist Candidate for 2023
- Is C3.ai Stock a ChatGPT Artificial Intelligence Play?
- Which Wireless Stock Should You Buy in 2023?
- Is Virgin Galactic Stock Preparing for Lift-Off?
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.